Carl Zeiss Meditec (AFX) Given a €76.50 Price Target by Independent Research Analysts

Independent Research set a €76.50 ($88.95) target price on Carl Zeiss Meditec (ETR:AFX) in a report published on Monday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Several other research firms have also weighed in on AFX. Deutsche Bank set a €71.00 ($82.56) price objective on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research report on Tuesday, February 12th. Nord/LB set a €92.00 ($106.98) price objective on shares of Carl Zeiss Meditec and gave the company a buy rating in a research report on Monday, February 11th. Berenberg Bank set a €68.00 ($79.07) price objective on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research report on Monday, February 11th. HSBC set a €80.00 ($93.02) price objective on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research report on Thursday, February 14th. Finally, Hauck & Aufhaeuser set a €78.50 ($91.28) price objective on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research report on Thursday, January 24th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company. The stock presently has an average rating of Hold and an average target price of €74.75 ($86.92).

ETR AFX opened at €78.50 ($91.28) on Monday. Carl Zeiss Meditec has a 1-year low of €51.05 ($59.36) and a 1-year high of €84.55 ($98.31). The firm has a market cap of $7.02 billion and a PE ratio of 55.52.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

See Also: How To Calculate Debt-to-Equity Ratio

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.